222 related articles for article (PubMed ID: 35202564)
1. Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism.
Franke M; Daly AF; Palmeira L; Tirosh A; Stigliano A; Trifan E; Faucz FR; Abboud D; Petrossians P; Tena JJ; Vitali E; Lania AG; Gómez-Skarmeta JL; Beckers A; Stratakis CA; Trivellin G
Am J Hum Genet; 2022 Apr; 109(4):553-570. PubMed ID: 35202564
[TBL] [Abstract][Full Text] [Related]
2. Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantism.
Caruso M; Mazzatenta D; Asioli S; Costanza G; Trivellin G; Franke M; Abboud D; Hanson J; Raverot V; Pétrossians P; Beckers A; Cappa M; Daly AF
Front Endocrinol (Lausanne); 2024; 15():1345363. PubMed ID: 38481440
[TBL] [Abstract][Full Text] [Related]
3. Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.
Iacovazzo D; Caswell R; Bunce B; Jose S; Yuan B; Hernández-Ramírez LC; Kapur S; Caimari F; Evanson J; Ferraù F; Dang MN; Gabrovska P; Larkin SJ; Ansorge O; Rodd C; Vance ML; Ramírez-Renteria C; Mercado M; Goldstone AP; Buchfelder M; Burren CP; Gurlek A; Dutta P; Choong CS; Cheetham T; Trivellin G; Stratakis CA; Lopes MB; Grossman AB; Trouillas J; Lupski JR; Ellard S; Sampson JR; Roncaroli F; Korbonits M
Acta Neuropathol Commun; 2016 Jun; 4(1):56. PubMed ID: 27245663
[TBL] [Abstract][Full Text] [Related]
4. The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism.
Daly AF; Beckers A
Endocr Rev; 2024 May; ():. PubMed ID: 38696651
[TBL] [Abstract][Full Text] [Related]
5. An orphan G-protein-coupled receptor causes human gigantism and/or acromegaly: Molecular biology and clinical correlations.
Trivellin G; Hernández-Ramírez LC; Swan J; Stratakis CA
Best Pract Res Clin Endocrinol Metab; 2018 Apr; 32(2):125-140. PubMed ID: 29678281
[TBL] [Abstract][Full Text] [Related]
6. The X-linked acrogigantism-associated gene gpr101 is a regulator of early embryonic development and growth in zebrafish.
Trivellin G; Tirosh A; Hernández-Ramírez LC; Gupta T; Tsai-Morris CH; Faucz FR; Burgess HA; Feldman B; Stratakis CA
Mol Cell Endocrinol; 2021 Jan; 520():111091. PubMed ID: 33248229
[TBL] [Abstract][Full Text] [Related]
7. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.
Trivellin G; Daly AF; Faucz FR; Yuan B; Rostomyan L; Larco DO; Schernthaner-Reiter MH; Szarek E; Leal LF; Caberg JH; Castermans E; Villa C; Dimopoulos A; Chittiboina P; Xekouki P; Shah N; Metzger D; Lysy PA; Ferrante E; Strebkova N; Mazerkina N; Zatelli MC; Lodish M; Horvath A; de Alexandre RB; Manning AD; Levy I; Keil MF; Sierra Mde L; Palmeira L; Coppieters W; Georges M; Naves LA; Jamar M; Bours V; Wu TJ; Choong CS; Bertherat J; Chanson P; Kamenický P; Farrell WE; Barlier A; Quezado M; Bjelobaba I; Stojilkovic SS; Wess J; Costanzi S; Liu P; Lupski JR; Beckers A; Stratakis CA
N Engl J Med; 2014 Dec; 371(25):2363-74. PubMed ID: 25470569
[TBL] [Abstract][Full Text] [Related]
8. Gigantism: X-linked acrogigantism and GPR101 mutations.
Iacovazzo D; Korbonits M
Growth Horm IGF Res; 2016; 30-31():64-69. PubMed ID: 27743704
[TBL] [Abstract][Full Text] [Related]
9. X-linked acrogigantism syndrome: clinical profile and therapeutic responses.
Beckers A; Lodish MB; Trivellin G; Rostomyan L; Lee M; Faucz FR; Yuan B; Choong CS; Caberg JH; Verrua E; Naves LA; Cheetham TD; Young J; Lysy PA; Petrossians P; Cotterill A; Shah NS; Metzger D; Castermans E; Ambrosio MR; Villa C; Strebkova N; Mazerkina N; Gaillard S; Barra GB; Casulari LA; Neggers SJ; Salvatori R; Jaffrain-Rea ML; Zacharin M; Santamaria BL; Zacharieva S; Lim EM; Mantovani G; Zatelli MC; Collins MT; Bonneville JF; Quezado M; Chittiboina P; Oldfield EH; Bours V; Liu P; W de Herder W; Pellegata N; Lupski JR; Daly AF; Stratakis CA
Endocr Relat Cancer; 2015 Jun; 22(3):353-67. PubMed ID: 25712922
[TBL] [Abstract][Full Text] [Related]
10. Mutations in GPR101 as a potential cause of X-linked acrogigantism and acromegaly.
Hou ZS; Tao YX
Prog Mol Biol Transl Sci; 2019; 161():47-67. PubMed ID: 30711029
[TBL] [Abstract][Full Text] [Related]
11. GPR101: Modeling a constitutively active receptor linked to X-linked acrogigantism.
Costanzi S; Stahr LG; Trivellin G; Stratakis CA
J Mol Graph Model; 2024 Mar; 127():108676. PubMed ID: 38006624
[TBL] [Abstract][Full Text] [Related]
12. Congenital hypopituitarism in two brothers with a duplication of the 'acrogigantism gene' GPR101: clinical findings and review of the literature.
Elizabeth MSM; Verkerk AJMH; Hokken-Koelega ACS; Verlouw JAM; Argente J; Pfaeffle R; Neggers SJCMM; Visser JA; de Graaff LCG
Pituitary; 2021 Apr; 24(2):229-241. PubMed ID: 33184694
[TBL] [Abstract][Full Text] [Related]
13. GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of G
Abboud D; Daly AF; Dupuis N; Bahri MA; Inoue A; Chevigné A; Ectors F; Plenevaux A; Pirotte B; Beckers A; Hanson J
Nat Commun; 2020 Sep; 11(1):4752. PubMed ID: 32958754
[TBL] [Abstract][Full Text] [Related]
14. GHRH excess and blockade in X-LAG syndrome.
Daly AF; Lysy PA; Desfilles C; Rostomyan L; Mohamed A; Caberg JH; Raverot V; Castermans E; Marbaix E; Maiter D; Brunelle C; Trivellin G; Stratakis CA; Bours V; Raftopoulos C; Beauloye V; Barlier A; Beckers A
Endocr Relat Cancer; 2016 Mar; 23(3):161-70. PubMed ID: 26671997
[TBL] [Abstract][Full Text] [Related]
15. Screening for genetic causes of growth hormone hypersecretion.
Rostomyan L; Beckers A
Growth Horm IGF Res; 2016; 30-31():52-57. PubMed ID: 27756606
[TBL] [Abstract][Full Text] [Related]
16. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: GPR101, an orphan GPCR with roles in growth and pituitary tumorigenesis.
Trivellin G; Faucz FR; Daly AF; Beckers A; Stratakis CA
Endocr Relat Cancer; 2020 Aug; 27(8):T87-T97. PubMed ID: 32240984
[TBL] [Abstract][Full Text] [Related]
17. X-LAG: How did they grow so tall?
Beckers A; Rostomyan L; Potorac I; Beckers P; Daly AF
Ann Endocrinol (Paris); 2017 Jun; 78(2):131-136. PubMed ID: 28457479
[TBL] [Abstract][Full Text] [Related]
18. [Overgrowth in children and in adults: novel clinical view, novel genes, novel phenotypes].
Lebl J; Plachý L; Bláhová K; Elblová L; Fencl F; Koloušková S; Průhová Š
Cas Lek Cesk; 2017; 156(5):233-240. PubMed ID: 28992707
[TBL] [Abstract][Full Text] [Related]
19. Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects.
Daly AF; Yuan B; Fina F; Caberg JH; Trivellin G; Rostomyan L; de Herder WW; Naves LA; Metzger D; Cuny T; Rabl W; Shah N; Jaffrain-Rea ML; Zatelli MC; Faucz FR; Castermans E; Nanni-Metellus I; Lodish M; Muhammad A; Palmeira L; Potorac I; Mantovani G; Neggers SJ; Klein M; Barlier A; Liu P; Ouafik L; Bours V; Lupski JR; Stratakis CA; Beckers A
Endocr Relat Cancer; 2016 Apr; 23(4):221-33. PubMed ID: 26935837
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
